0001213900-23-089631.txt : 20231122 0001213900-23-089631.hdr.sgml : 20231122 20231122164904 ACCESSION NUMBER: 0001213900-23-089631 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20231117 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20231122 DATE AS OF CHANGE: 20231122 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Avalon GloboCare Corp. CENTRAL INDEX KEY: 0001630212 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 471685128 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38728 FILM NUMBER: 231434111 BUSINESS ADDRESS: STREET 1: 4400 ROUTE 9 STREET 2: SUITE 3100 CITY: FREEHOLD STATE: NJ ZIP: 07728 BUSINESS PHONE: 732-780-4400 MAIL ADDRESS: STREET 1: 4400 ROUTE 9 STREET 2: SUITE 3100 CITY: FREEHOLD STATE: NJ ZIP: 07728 FORMER COMPANY: FORMER CONFORMED NAME: Avalon Globocare Corp. DATE OF NAME CHANGE: 20161018 FORMER COMPANY: FORMER CONFORMED NAME: GLOBAL TECHNOLOGIES CORP DATE OF NAME CHANGE: 20150108 8-K 1 ea188870-8k_avalonglobo.htm CURRENT REPORT
0001630212 false 0001630212 2023-11-17 2023-11-17 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): November 17, 2023

 

AVALON GLOBOCARE CORP.

(Exact name of registrant as specified in its charter)

 

Delaware   001-38728   47-1685128
(State or other jurisdiction
of incorporation)
  (Commission File Number)   (IRS Employer
Identification No.)

 

4400 Route 9 South, Suite 3100, Freehold, New Jersey   07728
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (732) 780-4400

 

N/A

 (Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, $0.0001 par value per share   ALBT   The Nasdaq Capital Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

 

 

Item 1.01. Entry into a Material Definitive Agreement.

 

Membership Interest Purchase Agreement

 

On November 17, 2023, Avalon Globocare Corp., a Delaware corporation (the “Company”), entered into a Membership Interest Purchase Agreement (the “Purchase Agreement”) with Wenzhao Lu (the “Purchaser”), pursuant to which (i) the Purchaser acquired from the Company 30% of the total outstanding membership interests of Avalon RT 9 Properties, LLC, a wholly owned subsidiary of the Company (“Avalon RT9”) for a cash purchase price of $3,000,000 (the “Acquisition”), and (ii) for a period of twelve months following the closing of the Acquisition, the Purchaser shall have the option to purchase from the Company up to an additional 70% of the outstanding membership interests of Avalon RT9 for a purchase price of up to $7,000,000. Avalon RT9 is the owner of real property located at 4400 Route 9 South, Freehold, New Jersey 07728 (the “Property”), where the Company maintains its principal office space. An independent third party performed a valuation of the Property prior to the parties’ entering into the Purchase Agreement.

 

The Purchaser is the Chairman of the Company’s Board of Directors.

 

The foregoing description of the Purchase Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Purchase Agreement, which is filed as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated herein by reference. 

 

Item 9.01 Financial Statement and Exhibits.

 

(d) Exhibits

 

Exhibit No.

  Description
10.1   Membership Interest Purchase Agreement, dated November 17, 2023, between Avalon Globocare Corp. and Wenzhao Lu.
104   Cover Page Interactive Data File. The cover page XBRL tags are embedded within the inline XBRL document (contained in Exhibit 101)

 

1

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  AVALON GLOBOCARE CORP.
     
Date: November 22, 2023 By: /s/ Luisa Ingargiola
  Name: Luisa Ingargiola
  Title: Chief Financial Officer

 

 

2

 

EX-10.1 2 ea188870ex10-1_avalonglobo.htm MEMBERSHIP INTEREST PURCHASE AGREEMENT, DATED NOVEMBER 17, 2023, BETWEEN AVALON GLOBOCARE CORP. AND WENZHAO LU

Exhibit 10.1

 

EXECUTION VERSION

 

MEMBERSHIP INTEREST PURCHASE AGREEMENT

 

between

 

Avalon GloboCare Corp., Seller

 

and

 

Wenzhao Lu, Purchaser

 

dated as of

 

November 17, 2023

 

 

 

 

TABLE OF CONTENTS

 

ARTICLE I DEFINITIONS   1
     
ARTICLE II PURCHASE AND SALE   3
     
ARTICLE III PURCHASE PRICE   4
     
ARTICLE IV INSPECTION   4
     
ARTICLE V CLOSING   5
     
ARTICLE VI CLOSING DELIVERIES   5
     
ARTICLE VII TAX MATTERS   6
     
ARTICLE VIII SELLER’S COVENANTS   6
     
ARTICLE IX REPRESENTATIONS AND WARRANTIES   7
     
ARTICLE X CONDITIONS TO CLOSING   8
     
ARTICLE XI ADDITIONAL AGREEMENTS   10
     
ARTICLE XII GENERAL PROVISIONS   11

 

-i-

 

 

This MEMBERSHIP INTEREST PURCHASE AGREEMENT (this “Agreement”), dated as of the 17th day of November, 2023 (the “Effective Date”), is entered into between Avalon GloboCare Corp., a Delaware corporation, having an address at 4400 Route 9 South, Suite 3100, Freehold, New Jersey 07728 (“Seller”), and Wenzhao Lu, an individual, having an address at 16 Evan Dr, Morganville, New Jersey 07751 (“Purchaser”).

 

RECITALS

 

WHEREAS, Seller owns ONE HUNDRED percent (100%) of the issued and outstanding membership interests (the “Membership Interests”) in Avalon RT 9 Properties, LLC, a New Jersey limited liability company (the “Company”);

 

WHEREAS, the Company is the property owner (the “Property Owner”) of a one hundred percent (100%) fee simple interest in the property located at 4400 Route 9 South, Freehold, Block 4 Lot 46.03, on the municipal Tax map of Freehold Township, New Jersey 07728 (the “Property”);

 

WHEREAS, Seller wishes to sell to Purchaser, and Purchaser wishes to purchase from Seller, Membership Interests comprising 30% of the total outstanding Membership Interests (the “Sale Membership Interests”), subject to the terms and conditions set forth herein;

 

WHEREAS, Purchaser is the Chairman of the Board of the Seller;

 

WHEREAS, the sale of the Sale Membership Interests to the Purchaser as provided herein (including the Purchase Price payable therefor) has been approved by the Board of Directors of the Seller in accordance with Section 144 of the Delaware General Corporation Law; and

 

NOW, THEREFORE, in consideration of the mutual covenants and agreements hereinafter set forth and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto hereby agree as follows:

 

ARTICLE I
DEFINITIONS

 

Accelerated Closing Date” has the meaning set forth in Section 5.01.

 

Agreement” has the meaning set forth in the Preamble.

 

Bring Down Certificate” has the meaning set forth in Section 6.01.

 

Business Day” means any day, other than a Saturday, Sunday or legal holiday, on which commercial banks in the City of New York are open for the general transaction of business.

 

Closing” has the meaning set forth in Section 5.01.

 

Closing Date” has the meaning set forth in Section 5.01.

 

Code” means the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder.

 

1

 

 

Company” has the meaning set forth in the Recitals.

 

Earnest Money Deposit” has the meaning set forth in Section 3.01.

 

Effective Date” has the meaning set forth in the Preamble.

 

Encumbrance” has the meaning set forth in Section 2.01.

 

Existing Mortgage Documents” means: (a) that certain Mortgage and Security Agreement, dated as of September 1, 2022, entered into between the Property Owner, as borrower, and S&P Principal LLC (“S&P”), in the principal amount of FOUR MILLION EIGHT HUNDRED THOUSAND Dollars ($4,800,000); (b) that certain Second Mortgage and Security Agreement, dated May 24, 2023, entered into between the Property Owner and S&P, in the principal amount of ONE MILLION Dollars ($1,000,000); (c) that certain Mortgage and Security Agreement, dated as of October 9, 2023, entered into between the Property Owner, Mast Hill Fund, L.P. and FirstFire Global Opportunities Fund LLC (together with S&P, the “Lenders”), in the principal amount of SEVEN HUNDRED THOUSAND Dollars ($700,000); and (d) all other documents and agreements evidencing and securing repayment of the Existing Mortgage Financing.

 

Existing Mortgage Financing” means the mortgage loans made by the Lenders to the Company in the original principal amount of SIX MILLION FIVE HUNDRED THOUSAND Dollars ($6,500,000) as evidenced by the Existing Mortgage Documents.

 

Indemnified Parties” means Seller, Managing Member, the Property Owner, and the Company, and their respective disclosed or undisclosed, direct and indirect shareholders, officers, directors, trustees, partners, principals, members, employees, agents, affiliates, representatives, consultants, accountants, contractors, and attorneys or other advisors, and any successors or assigns of the foregoing.

 

Joinder” has the meaning set forth in Section 6.02.

 

Managing Member” means the sole Member under the Operating Agreement.

 

Managing Member Approval” shall have the meaning set forth in Section 10.03.

 

Membership Interests” has the meaning set forth in the Recitals.

 

Membership Interest Call Notice” has the meaning set forth in Section 11.01.

 

Membership Interest Call Price” has the meaning set forth in Section 11.01.

 

Membership Interest Call Transaction” has the meaning set forth in Section 11.01.

 

Membership Interest Purchase Option” has the meaning set forth in Section 11.01.

 

Operating Agreement” means that certain Operating Agreement of the Company dated February 28, 2017 entered into between Seller, as sole member and the Company;

 

2

 

 

Organizational Documents” means with respect to the Company and the Property Owner, the articles of organization or certificate of formation, as applicable, the Operating Agreement, member resolutions, certificates evidencing the membership interests, if any, and all amendments or modifications to the foregoing and similar governing instruments required by the laws of the governing jurisdiction of formation or organization.

 

Option Exercise MIPA” has the meaning set forth in Section 11.01.

 

Option Period” has the meaning set forth in Section 11.01.

 

Permitted Encumbrance” means any mortgage, pledge, lien, charge, or security interest resulting from the Existing Mortgage Financing.

 

Pre-Closing Tax Period” means any taxable period of the Company that ends on or before the Closing Date and the portion of any Straddle Period through the end of the Closing Date.

 

Property” has the meaning set forth in the Recitals.

 

Property Owner” has the meaning set forth in the Recitals.

 

Purchase Price” has the meaning set forth in Section 3.01.

 

Purchaser” has the meaning set forth in the Preamble.

 

Purchaser’s Representatives” has the meaning set forth in Section 4.01.

 

Sale Membership Interests” has the meaning set forth in the Recitals.

 

Seller” has the meaning set forth in the Preamble.

 

Tax” or “Taxes” means any federal, state, local, foreign, or other tax, fee, levy, duty, assessment, or other governmental charge, any amounts paid under an agreement with a governmental authority relating to a tax or in lieu of a tax, and any interest, additions to tax, and penalties in connection therewith.

 

Tax Return” means any return, report, information return, declaration, claim for refund, or other document, together with all amendments, attachments, and supplements thereto (including all related or supporting information), required to be maintained for or supplied to any governmental authority responsible for the administration or collection of Taxes.

 

ARTICLE II
PURCHASE AND SALE

 

Section 2.01 Sale Membership Interests. Seller agrees to sell to Purchaser, and Purchaser agrees to purchase from Seller, in accordance with the terms and conditions of this Agreement, the Sale Membership Interests, free and clear of any mortgage, pledge, lien, charge, security interest, claim or other encumbrance (“Encumbrance”) other than a Permitted Encumbrance, but subject to the terms and restrictions of: (a) the Operating Agreement; and (b) the Existing Mortgage Documents. For purposes hereof, the Sale Membership Interests shall include but are not limited to: (i) the Seller’s portion of the capital account in the Company corresponding to the Sale Membership Interests; (ii) the Seller’s right to share in the profits and losses of the Company based on the percentage ownership of the Company evidenced by the Sale Membership Interests; (iii) the Seller’s right to receive distributions from the Company based on the percentage ownership of the Company evidenced by the Sale Membership Interests; and (iv) all of the voting rights attributable to the Sale Membership Interests.

 

3

 

 

ARTICLE III
PURCHASE PRICE

 

Section 3.01 Purchase Price.

 

(a) The purchase price for the Sale Membership Interests is THREE MILLION Dollars ($3,000,000) (the “Purchase Price”).

 

(b) The Purchaser shall pay the Purchase Price to Seller in cash, by wire transfer of immediately available funds to an account of Seller in accordance with the wire instructions set forth on Schedule I, as follows:

 

(i) The sum of three hundred thousand dollars ($300,000) (the “Earnest Money Deposit”), upon the execution of this Agreement; and

 

(ii) The balance of the Purchase Price in the amount of two million seven hundred thousand dollars ($2,700,000), on the Closing Date.

 

ARTICLE IV
INSPECTION

 

Section 4.01 Purchaser’s Inspection Rights. Purchaser and its agents, employees, consultants, inspectors, and appraisers (collectively ‘Purchaser’s Representatives’) shall have the right from time to time through the Closing Date, to the extent in Seller’s possession or control, to have access to and inspect all books and records, contracts, financial, operating, tax, organizational, and other documents and information related to the Company as Purchaser or Purchaser’s Representatives may reasonably request. Notwithstanding any such inspection, or anything to the contrary herein contained, Purchaser’s obligations hereunder shall not be limited or otherwise affected as a result of any fact, circumstance, or other matter of any kind discovered following the date hereof in connection with any such inspection, access, or otherwise; it being agreed that Seller is permitting Purchaser such right of inspection and access as a courtesy to Purchaser in its preparation for purchasing the Membership Interests. Without limiting the generality of the foregoing: (a) Purchaser agrees that it shall not have any so-called “due diligence period” and that it shall have no right to terminate this Agreement or obtain a reduction of the Purchase Price because of any such fact, circumstance, or other matter so discovered; and (b) Purchaser shall have no right to terminate this Agreement or obtain a return of the Earnest Money Deposit except as otherwise expressly provided in this Agreement. If the Closing under this Agreement shall not occur for any reason whatsoever, Purchaser shall promptly return to Seller copies of all due diligence materials delivered by Seller to Purchaser and shall destroy all copies and abstracts thereof.

 

4

 

 

ARTICLE V

CLOSING

 

Section 5.01 Closing; Closing Date. The closing of the transaction contemplated hereby (the “Closing”) shall occur at 12:01 a.m. Eastern standard time on December 31, 2023 (the “Closing Date”) in accordance with the terms and conditions of this Agreement, at the offices of Lowenstein Sandler LLP, located at 1251 Avenue of the Americas, New York, NY 10020. The Closing and exchange of documents may also take place by facsimile or other electronic transmission. The consummation of the transactions contemplated by this Agreement shall be deemed to occur at 12:01 a.m. on the Closing Date. Notwithstanding the foregoing,

 

(a) The Closing Date may be accelerated to a date that is mutually agreed upon by the Purchaser and the Seller (such accelerated date, the “Accelerated Closing Date”).

 

(b) The Seller and the Purchaser shall be entitled to adjourn the Closing Date or the Accelerated Closing Date one or more times on at least ten (10) Business Days’ notice to the other party to satisfy any conditions to such party’s obligations to consummate the Closing under this Agreement.

 

(c) The Closing Date, Accelerated Closing Date, and/or any other date to which the Closing is adjourned or accelerated in accordance with the terms of this Agreement shall be deemed the “Closing Date” hereunder.

 

Purchaser acknowledges and agrees that time shall be of the essence with respect to the performance by Purchaser of its obligations to purchase the Sale Membership Interests, pay the Purchase Price, and otherwise consummate the transactions contemplated in this Agreement on the Closing Date.

 

ARTICLE VI
CLOSING DELIVERIES

 

Section 6.01 Seller’s Closing Deliveries. Seller shall deliver or cause to be delivered to Purchaser the following at the Closing, except as otherwise specified below:

 

(a) A consent of the board of directors of Seller authorizing the transaction contemplated hereby and the execution and delivery of the documents required to be executed and delivered hereunder.

 

(b) The Managing Member Approval.

 

(c) A revised Members’ Schedule (Exhibit A to the Operating Agreement and Exhibit A hereto) reflecting the Purchaser’s purchase of the Sale Membership Interests and ownership interest in the Company.

 

(d) A written certificate stating that all representations and warranties contained in Section 9.01 remain, as of the Closing Date, true, correct, and complete in all material respects as when first made hereunder (the “Bring Down Certificate”).

 

(e) A valid and properly executed Internal Revenue Service Form W-9.

 

5

 

 

Section 6.02 Purchaser’s Closing Deliveries. On the Closing Date, Purchaser shall deliver or cause to be delivered to Seller the following:

 

(a) The balance of the Purchase Price as set forth in Section 3.01(b).

 

(b) The Joinder Agreement, executed by the Purchaser, a form of which is set forth in Exhibit B hereto (the “Joinder”).

 

ARTICLE VII
TAX MATTERS

 

Section 7.01 Allocations of Company Income and Loss. For the avoidance of doubt, Seller and Purchaser agree that the Company as a disregarded entity for income tax purposes shall allocate all items of Company income, gain, loss, deduction, or credit attributable to the Sale Membership Interests for the taxable year of the Closing through the Closing Date to Seller and that after the Closing Date, the Company, which will be treated as a partnership for income tax purposes, shall allocate all items of Company income, gain, loss, deduction, or credit attributable to the Sale Membership Interests to Seller and Purchaser for the taxable year of the Closing after the Closing Date as provided in the Operating Agreement.

 

Section 7.02 Tax Audit Procedures. Seller shall be the partnership representative for purposes of Subchapter C of Chapter 63 of the Code, as revised by Section 1101 of the Bipartisan Budget Act of 2015, as such provisions may thereafter be amended and including Treasury Regulations or other guidance issued thereunder.

 

Section 7.03 Transfer Taxes. Seller shall pay, and shall reimburse Purchaser for, any sales, use or transfer taxes, documentary charges, recording fees or similar taxes, charges, fees, or expenses, if any, that become due and payable as a result of the transactions contemplated by this Agreement.

 

ARTICLE VIII
selleR’s covenants

 

Section 8.01 Seller’s Covenants. Seller covenants that:

 

(a) From the Effective Date until the Closing, Seller shall:

 

(i) Bear the cost of all Taxes required to be paid by the Company for any Pre-Closing Tax Periods; and

 

(ii) Promptly deliver or cause to be delivered to Purchaser, upon request, copies of the most recent financial statements of the Company.

 

(b) From the Effective Date until the Closing, the Seller shall not, without Purchaser’s prior written approval, which approval shall not be unreasonably withheld:

 

(i) Enter into any agreement that would require the consent of a third party to consummate the transactions contemplated by this Agreement;

 

(ii) Sell, transfer, encumber, or change the status of title of all or any portion of the Sale Membership Interests; or

 

(iii) Consent to any amendment to the Organizational Documents that would materially affect Seller’s rights or obligations in the Company.

 

6

 

 

ARTICLE IX

REPRESENTATIONS AND WARRANTIES

 

Section 9.01 Seller’s Representations and Warranties.

 

(a) Seller represents and warrants to the Purchaser and the Company that:

 

(i) Seller is a corporation duly formed and in good standing under the laws of the State of Delaware. Seller has the corporate power to enter into and perform this Agreement in accordance with its terms. The execution, delivery and performance of this Agreement, including the sale of the Sale Membership Interests to the Purchaser as contemplated hereby, has been duly authorized by the Seller and the Company.;

 

(ii) This Agreement has been duly executed and delivered by the Seller and constitutes the valid and binding obligation of the Seller, enforceable against the Seller in accordance with its terms, subject to bankruptcy, reorganization, and other similar laws affecting the enforcement of creditors’ rights generally and to general equity principles;

 

(iii) Schedule II is a true, correct, and complete list of all Organizational Documents of the Company;

 

(iv) The sale of the Sale Membership Interests as contemplated hereby does not violate any preemptive or similar rights of any person under the Organizational Documents of the Company or any agreement, arrangement or other understanding to which either the Seller or the Company is a party or by which either of them is bound or the Sale Membership Interests are subject;

 

(v) Seller has good and valid title to the Membership Interests, including the Sale Membership Interests, free and clear of all liens, pledges, charges, security interests, rights of first refusal, purchase options, or other Encumbrances of any kind;

 

(b) All representations and warranties made to Seller’s knowledge in this Agreement are made based on the actual knowledge of Luisa Ingargiola, without any duty to review or investigate the matters to which such knowledge, or the absence thereof, pertains and with no imputed knowledge whatsoever, whether from any partner, officer, director, member, shareholder, or employee of Seller. Luisa Ingargiola shall have no personal liability arising out of any representations or warranties made herein.

 

7

 

 

Section 9.02 Purchaser’s Representations and Warranties. Purchaser represents and warrants to the Seller and the Company that:

 

(a) Purchaser has the legal capacity to enter into and perform this Agreement in accordance with its terms.

 

(b) This Agreement has been duly executed and delivered by the Purchaser and constitutes the valid and binding obligation of the Purchaser, enforceable against the Purchaser in accordance with its terms, subject to bankruptcy, reorganization, and other similar laws affecting the enforcement of creditors’ rights generally and to general equity principles.

 

(c) The purchase of the Sale Membership Interests as contemplated hereby does not violate any agreement, arrangement or other understanding to which the Purchaser is a party or by which he is bound. The Purchaser has readily available cash resources in an amount sufficient for him to complete the purchase of the Sale Membership Interests, including the payment of the Purchase Price as contemplated hereby.

 

(d) Purchaser is an “accredited investor” as such term is defined in Rule 501 of Regulation D under the Securities Act of 1933, as amended (the “Securities Act”). Purchaser is acquiring the Sale Membership Interests solely for his own account for investment purposes and not with a view to, or for offer or sale in connection with, any distribution thereof in violation of the Securities Act. Purchaser acknowledges that the Sale Membership Interests constitute “restricted securities” under Rule 144 under the Securities Act, have not been registered under the Securities Act, or any state securities laws, and that the Sale Membership Interests may not be transferred or sold except pursuant to the registration provisions of the Securities Act or pursuant to an applicable exemption therefrom and subject to state securities laws and regulations, as applicable. The Purchaser acknowledges that an appropriate transfer restriction above will be noted in the Company’s books and records and will be placed on any certificate representing any of the Sale Membership Interests.

 

ARTICLE X
CONDITIONS TO CLOSING

 

Section 10.01 Conditions to Obligations of Seller. Notwithstanding anything to the contrary contained herein, the obligation of Seller to close the transaction in accordance with this Agreement is expressly conditioned on the fulfillment by and as of the Closing Date of each of the conditions listed below, provided that Seller, at its election, evidenced by written notice delivered to Purchaser at or prior to the Closing, may waive any of such conditions:

 

(a) Purchaser shall have: (i) executed and delivered to Seller all documents required to be delivered by Purchaser at Closing; (ii) paid the full balance of the Purchase Price in accordance with Section 3.01(b); and (iii) paid all other sums of money required under this Agreement, if any.

 

(b) Purchaser shall not be in default of any covenant or agreement to be performed by Purchaser under this Agreement and shall have performed all other obligations required to be performed by it under this Agreement on or prior to the Closing Date.

 

(c) On the Closing Date, all representations and warranties made by Purchaser in Section 9.02 shall be true and correct as if made on the Closing Date.

 

(d) The Managing Member Approval shall have been obtained pursuant to Section 10.03 hereof.

 

8

 

 

Section 10.02 Conditions to Obligations of Purchaser. Notwithstanding anything to the contrary contained herein, the obligation of Purchaser to close the transaction and pay the Purchase Price in accordance with this Agreement is expressly conditioned on the fulfillment by and as of the Closing Date of each of the conditions listed below, provided that Purchaser, at its election, evidenced by written notice delivered to Seller at or prior to the Closing, may waive all or any of such conditions:

 

(a) Seller shall have executed and delivered to Purchaser all documents required to be delivered by Seller at the Closing and shall have taken all other action required of Seller at the Closing.

 

(b) All representations and warranties made by Seller in Section 9.01 shall be true and correct in all material respects as if made on the Closing Date; provided, however, to the extent the facts and circumstances underlying such representations and warranties may have changed as of the Closing Date, Seller shall have the right to update its representations and warranties as of the Closing Date.

 

(c) The Managing Member Approval shall have been delivered pursuant to Section 10.03.

 

Section 10.03 Managing Member Approval. The Managing Member’s consent to the: (a) transfer of the Sale Membership Interests to Purchaser (or its designee); and (b) admission of the Purchaser (or its designee) as a member in the Company (the “Managing Member Approval”) shall be a condition precedent to Purchaser’s and Seller’s obligation to close the transaction under this Agreement. The Managing Member Approval shall be in form and substance acceptable to Purchaser and substantially in the form attached hereto as Exhibit C. Seller shall use commercially reasonable efforts to obtain and deliver to Purchaser the Managing Member Approval.

 

Section 10.04 Failure of Conditions to Closing.

 

(a) If, except as provided in 10.04(c), Purchaser is unable to timely satisfy (and Seller has not waived in writing) the conditions precedent to Seller’s obligation to effect the Closing, then such failure shall constitute a default hereunder, in which case, Seller shall have the right to terminate this Agreement by notice thereof to Purchaser in accordance with the terms of this Agreement. If this Agreement is so terminated, then Seller shall be entitled to receive the Earnest Money Deposit and thereafter, neither Party shall have any further obligations hereunder, except those expressly stated to survive the termination hereof, if any.

 

(b) If Seller is unable to timely satisfy the conditions precedent to Purchaser’s obligation to effect the Closing (and Purchaser has not waived the same in writing), then Seller may, if it so elects and without any abatement in the Purchase Price: (i) adjourn the Closing Date for a period or periods not to exceed twenty (20) Business Days in the aggregate after the Closing Date; and (ii) if, after any such extension, the conditions precedent to Purchaser’s obligation to effect the Closing continue not to be satisfied (and Purchaser has not waived the same in writing) or Seller does not elect such extension and, in either case, such failure of condition precedent is not the result of Seller’s default hereunder, then Purchaser or Seller shall be entitled to terminate this Agreement by notice thereof to the other Party in accordance with the terms of this Agreement. If this Agreement is so terminated, then Purchaser shall be entitled to receive the Earnest Money Deposit and thereafter neither Party shall have any further obligations hereunder, except those expressly stated to survive the termination hereof, if any.

 

(c) If the Managing Member Approval has not been obtained by the Closing Date, then provided that both parties have used reasonably diligent efforts to obtain the approval and are not otherwise in default under this Agreement, either Purchaser or Seller shall be entitled to terminate this Agreement by notice thereof to the other Party in accordance with the terms of this Agreement. If this Agreement is so terminated, then Purchaser shall be entitled to receive the Earnest Money Deposit and thereafter neither Party shall have any further obligations hereunder, except those expressly stated to survive the termination hereof, if any.

 

9

 

 

ARTICLE XI
ADDITIONAL AGREEMENTS

 

Section 11.01 Additional Membership Interest Purchase Option.

 

(a) At any time during the period beginning on the Closing Date and ending on the date twelve (12) months after the Closing Date (the “Option Period”), Purchaser shall have the right (the “Membership Interest Purchase Option”), upon delivery of a written notice stating the Purchaser’s intent to exercise its rights pursuant to this Section 11.01 (and the number of Membership Interests the Purchaser intends to purchase from Seller) (a “Membership Interest Call Notice”), to purchase, from the Seller up to seventy percent (70%) of the Membership Interests for up to Seven Million dollars ($7,000,000) in cash (the “Membership Interest Call Price”), and in accordance with the procedures and on the terms and conditions set forth in this Section 11.01 (the “Membership Interest Call Transaction”), provided, however, that if the Purchaser elects to exercise the Membership Interest Purchase Option within the Option Period, and has delivered the Membership Interest Call Notice within such Option Period, but requires additional time to close the Membership Interest Call Transaction and in good faith believes that Purchaser will be able to obtain the necessary capital to close the Membership Interest Call Transaction, then, prior to the expiration of the Option Period, the Purchaser shall reaffirm their exercise of the Membership Interest Purchase Option in writing to the Seller and accompany such reaffirmation with reasonable evidence of financial commitments for the Membership Interest Call Price, and the Purchaser shall have an additional ninety (30) day period to execute and deliver the membership interest purchase agreement with respect to the Membership Interest Call Transaction. In the event the Purchaser fails to provide such reaffirmation prior to the end of the Option Period, the Membership Interest Purchase Option shall terminate on December 31,2024, unless otherwise agreed to by the parties.

 

(b) Promptly following the delivery of a Membership Interest Call Notice by the Purchaser, the Purchaser and the Seller shall cooperate in good faith to execute and deliver a membership interest purchase agreement (the “Option Exercise MIPA”), substantially in the same form as this Agreement, with such other changes as otherwise agreed upon by the Purchaser and the Seller at the time the Membership Interest Call Notice is exercised, which Option Exercise MIPA shall include, among others, covenants: (i) for the repayment of the Existing Mortgage Financing by the Seller or the Company, as the case may be, immediately following the closing under the Option Exercise MIPA from the proceeds of the Membership Interest Call Transaction and release of all liens related thereto; and (ii) to cooperate in good faith between the Seller and the Purchaser to file all necessary tax, recording of title and other filings that may be required to be filed in connection with the transfer of all rights, title and interest in the Membership Interests and the Property by Seller to Purchaser. In addition, Purchaser shall have the right, at his sole expense, (i) to perform or cause to be performed building inspections of the Property, (ii) to request title reports in relation to the Property, and (iii) to retain a title company or legal counsel as his closing agent. The definitive terms of any Membership Interest Call Transaction shall be set forth in the Option Exercise MIPA.

 

(c) Each of the Purchaser and the Seller shall bear its own costs and expenses incurred in connection with any Membership Interest Call Transaction (whether or not consummated), including all attorneys’ fees and charges, all accounting fees and charges and all finders, brokerage or investment banking fees, charges or commissions.

 

(d) Each of the Purchaser and the Seller shall execute and deliver all related documentation and take such other action in support of a Membership Interest Call Transaction as shall be reasonably requested by either party in order to carry out the terms and provisions of this Section 11.01.

 

(e) Upon the closing of the Membership Interest Call Transaction, the Purchaser and the Seller shall if requested by the Purchaser, amend and restate the Operating Agreement.

 

10

 

 

ARTICLE XII
GENERAL PROVISIONS

 

Section 12.01 Expenses. All costs and expenses incurred in connection with this Agreement and the transactions contemplated hereby shall be paid by the party incurring such costs and expenses.

 

Section 12.02 Further Assurances. Following the Closing, each of the parties hereto shall, and shall cause their respective affiliates to, execute and deliver such additional documents, instruments, conveyances and assurances and take such further actions as may be reasonably required to carry out the provisions hereof and give effect to the transactions contemplated by this Agreement.

 

Section 12.03 Notices. All notices, requests, consents, claims, demands, waivers and other communications hereunder shall be in writing and shall be deemed to have been given (a) when delivered by hand (with written confirmation of receipt); (b) when received by the addressee if sent by a nationally recognized overnight courier (receipt requested); (c) on the date sent by facsimile or e-mail of a PDF document (with confirmation of transmission) if sent during normal business hours of the recipient, and on the next Business Day if sent after normal business hours of the recipient or (d) on the third day after the date mailed, by certified or registered mail, return receipt requested, postage prepaid. Such communications must be sent to the respective parties at the following addresses (or at such other address for a party as shall be specified in a notice given in accordance with this Section 12.03:

 

If to the Seller:

Avalon GloboCare Corp.

4400 Route 9 South, Suite 3100

Freehold, New Jersey 07728

E-mail: luisa@avalon-globocare.com

Attention: Luisa Ingargiola

   

with a copy to (which shall not constitute notice):

 

 

 

 

 

If to the Purchaser:

Lowenstein Sandler LLP

1251 Avenue of the Americas

New York, NY 10020

E-mail: sskolnick@lowenstein.com

Attention: Steven Skolnick

 

Wenzhao Lu

16 Evan, Morganville, NJ 07751

E-mail: Daniel@avalon-globocare.com

Attention: Wenzhao Lu

 

11

 

 

Section 12.04 Headings. The headings in this Agreement are for reference only and shall not affect the interpretation of this Agreement.

 

Section 12.05 Severability. If any term or provision of this Agreement is invalid, illegal or unenforceable in any jurisdiction, such invalidity, illegality or unenforceability shall not affect any other term or provision of this Agreement or invalidate or render unenforceable such term or provision in any other jurisdiction. Upon such determination that any term or other provision is invalid, illegal or unenforceable, the parties hereto shall negotiate in good faith to modify the Agreement so as to effect the original intent of the parties as closely as possible in a mutually acceptable manner in order that the transactions contemplated hereby be consummated as originally contemplated to the greatest extent possible.

 

Section 12.06 Entire Agreement. This Agreement and the documents to be delivered hereunder constitute the sole and entire agreement of the parties to this Agreement with respect to the subject matter contained herein, and supersede all prior and contemporaneous understandings and agreements, both written and oral, with respect to such subject matter. In the event of any inconsistency between the statements in the body of this Agreement and those in documents to be delivered hereunder, the Exhibits and the Schedules, the statements in the body of this Agreement will control.

 

Section 12.07 Successors and Assigns. This Agreement shall be binding upon and shall inure to the benefit of the parties hereto and their respective successors and permitted assigns. Neither party may assign its rights or obligations hereunder without the prior written consent of the other party, which consent shall not be unreasonably withheld or delayed. No assignment shall relieve the assigning party of any of its obligations hereunder.

 

Section 12.08 No Third-Party Beneficiaries. This Agreement is for the sole benefit of the parties hereto and their respective successors and permitted assigns and nothing herein, express or implied, is intended to or shall confer upon any other person or entity any legal or equitable right, benefit or remedy of any nature whatsoever under or by reason of this Agreement.

 

Section 12.09 Amendment and Modification. This Agreement may only be amended, modified or supplemented by an agreement in writing signed by each party hereto.

 

Section 12.10 Waiver. No waiver by any party of any of the provisions hereof shall be effective unless explicitly set forth in writing and signed by the party so waiving. No waiver by any party shall operate or be construed as a waiver in respect of any failure, breach or default not expressly identified by such written waiver, whether of a similar or different character, and whether occurring before or after that waiver. No failure to exercise, or delay in exercising, any right, remedy, power or privilege arising from this Agreement shall operate or be construed as a waiver thereof; nor shall any single or partial exercise of any right, remedy, power or privilege hereunder preclude any other or further exercise thereof or the exercise of any other right, remedy, power or privilege.

 

Section 12.11 Governing Law. This Agreement shall be governed by and construed in accordance with the internal laws of the State of New Jersey without giving effect to any choice or conflict of law provision or rule (whether of the State of New Jersey or any other jurisdiction).

 

12

 

 

Section 12.12 Submission to Jurisdiction. EACH PARTY HERETO AGREES THAT ALL ACTIONS OR PROCEEDINGS ARISING IN CONNECTION WITH THIS AGREEMENT AND THE TRANSACTIONS CONTEMPLATED HEREBY SHALL BE TRIED AND LITIGATED IN STATE OR FEDERAL COURTS LOCATED IN THE STATE OF NEW JERSEY, UNLESS SUCH ACTIONS OR PROCEEDINGS ARE REQUIRED TO BE BROUGHT IN ANOTHER COURT TO OBTAIN SUBJECT MATTER JURISDICTION OVER THE MATTER IN CONTROVERSY. TO THE EXTENT PERMITTED BY LAW, EACH PARTY HERETO IRREVOCABLY WAIVES ANY RIGHT ANY PARTY HERETO MAY HAVE TO ASSERT THE DOCTRINE OF FORUM NON CONVENIENS, TO ASSERT THAT ANY PARTY HERETO IS NOT SUBJECT TO THE JURISDICTION OF THE AFORESAID COURTS, OR TO OBJECT TO VENUE TO THE EXTENT ANY PROCEEDING IS BROUGHT IN ACCORDANCE WITH THIS ARTICLE XII. SERVICE OF PROCESS, SUFFICIENT FOR PERSONAL JURISDICTION IN ANY ACTION AGAINST ANY PARTY HERETO, MAY BE MADE BY REGISTERED OR CERTIFIED MAIL, RETURN RECEIPT REQUESTED, TO ANY SUCH PARTY’S ADDRESS INDICATED IN SECTION 12.03 HEREOF.

 

Section 12.13 Waiver of Jury Trial. EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS AGREEMENT IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES AND, THEREFORE, EACH SUCH PARTY IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LEGAL ACTION ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY. EACH PARTY TO THIS AGREEMENT CERTIFIES AND ACKNOWLEDGES THAT (A) NO REPRESENTATIVE OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT SEEK TO ENFORCE THE FOREGOING WAIVER IN THE EVENT OF A LEGAL ACTION, (B) SUCH PARTY HAS CONSIDERED THE IMPLICATIONS OF THIS WAIVER, (C) SUCH PARTY MAKES THIS WAIVER VOLUNTARILY, AND (D) SUCH PARTY HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION 12.13.

 

Section 12.14 Counterparts. This Agreement may be executed in counterparts, each of which shall be deemed an original, but all of which together shall be deemed to be one and the same agreement. A signed copy of this Agreement delivered by facsimile, e-mail or other means of electronic transmission shall be deemed to have the same legal effect as delivery of an original signed copy of this Agreement.

 

[Signature Page Follows]

 

13

 

 

IN WITNESS WHEREOF, the parties have caused this Agreement to be executed as of the date first written above.

 

PURCHASER:

 

WENZHAO LU

 

By: /s/ Wenzhao Lu  
  Name: Wenzhao Lu  
  Title:  

 

SELLER:

 

AVALON GLOBOCARE CORP., a Delaware corporation

 

By: /s/ Luisa Ingargiola  
  Name: Luisa Ingargiola  
  Title: CFO  

 

14

 

 

EXHIBITS

 

Schedule I   Wire Instructions
Schedule II   Organizational Documents of the Company
Exhibit A   Members’ Schedule
Exhibit B   Joinder Agreement
Exhibit C   Managing Member Approval

 

15

 

 

Schedule I

 

Wire Instructions

 

 

 

 

 

16

 

 

Schedule II

 

Organizational Documents of the Company

 

 

 

 

17

 

 

Exhibit A

 

MEMBERS’ SCHEDULE

 

Member  Capital
Contribution
   Number Series A
Membership
Interests
  %
Ownership
 
Avalon Globocare Corp.  $7,070,228   1-70   70%
Wenzhao Lu  $3,000,000   71-100   30%

 

18

 

 

Exhibit B

 

JOINDER AGREEMENT

 

The undersigned is executing and delivering this Joinder Agreement pursuant to the Operating Agreement of Avalon RT 9 Properties, LLC, a New Jersey limited liability company (the “Company”), dated as of February 28, 2017 (as in effect from time to time, the “Operating Agreement”), by and among the Company and its Members party thereto.

 

By executing and delivering this Joinder Agreement to the Operating Agreement, the undersigned hereby agrees to become a party to, to be bound by, and to comply with the provisions of the Operating Agreement in the same manner as if the undersigned were an original signatory to such agreement as a Member. In connection therewith, effective as of the date hereof the undersigned hereby makes the representations and warranties contained in the Operating Agreement.

 

Accordingly, the undersigned has executed and delivered this Joinder Agreement as of the __ day of _______, 2023.

 

   
  Signature of Member
   
   
  Print Name of Member

 

19

 

 

Exhibit C

 

WRITTEN CONSENT OF THE SOLE MEMBER

 

OF AVALON RT 9 PROPERTIES, LLC

 

Dated as of December __, 2023

 

The undersigned, being the sole member (the “Sole Member”) of Avalon RT 9 Properties, LLC, a New Jersey limited liability company (the “Company”), in lieu of holding a meeting of the Sole Member, hereby waives any notice and other requirements for the holding of a meeting of the members and takes the following actions and adopts the following resolutions by written consent with the same force and effect as if they have been adopted at a duly called meeting, pursuant to the applicable laws of the jurisdiction in which the Company is organized. Capitalized terms used but not defined herein have the meanings ascribed to such terms in the Purchase Agreement (as defined below):

 

WHEREAS, Avalon GloboCare Corp., a Delaware corporation (the “Seller”), owns ONE HUNDRED percent (100%) of the issued and outstanding membership interests in the Company (the “Membership Interests”);

 

WHEREAS, the Company is the property owner of a one hundred percent (100%) fee simple interest in the property located at 4400 Route 9 South, Freehold, Block 4 Lot 46.03, on the municipal Tax map of Freehold Township, New Jersey 07728;

 

WHEREAS, the Company desires to enter into that certain Membership Interest Purchase Agreement (together with all exhibits, schedules and attachments thereto, the “Purchase Agreement”), by and among Wenzhao Lu (“Purchaser”) and the Seller, a copy of which is attached hereto as Exhibit A, pursuant to which, among other things, Purchaser shall purchase from the Seller thirty percent (30%) of the Membership Interests, on the terms and subject to the conditions set forth in the Purchase Agreement (the “Transaction”);

 

WHEREAS, the Transaction is proposed to be effected pursuant to the terms and conditions of the Purchase Agreement; and

 

WHEREAS, the Transaction has been approved by the Board of Directors of the Seller.

 

NOW, THEREFORE, BE IT:

 

RESOLVED, that the Purchase Agreement, the performance thereof by the Company and the consummation by the Company of the Transaction contemplated thereby be, are each authorized, approved, ratified and confirmed in all respects, with such changes therein and additions thereto as the proper officers of the Company shall approve, the execution and delivery thereof to be conclusive evidence of such approval; and be it further

 

RESOLVED, that the proper officers of the Company be, and each of them hereby is, authorized, empowered and directed, in the name and on behalf of the Company, to execute and deliver, and to cause to be performed the obligations of the Company under, the Purchase Agreement, with such changes therein and additions thereto as the proper officers of the Company shall approve, the execution and delivery thereof to be conclusive evidence of such approval; and be it further

 

RESOLVED, that the proper officers of the Company be, and each of them hereby is, authorized and directed, in the name and on behalf of the Company, to take or cause to be taken any and all such further actions and to prepare, execute and deliver or cause to be prepared, executed and delivered all such further agreements, documents, certificates and undertakings, and to incur all such fees and expenses, as in his or her judgment shall be necessary, appropriate or advisable to carry out and effectuate the purpose and intent of any and all of the foregoing resolutions; and be it further

 

RESOLVED, that all actions previously taken by any officer, manager, representative or agent of the Company, in the name or on behalf of the Company or any of its affiliates in connection with the transactions contemplated by the foregoing resolutions be, and each of the same hereby is, adopted, ratified, confirmed and approved in all respects as the act and deed of the Company; and be it further

 

RESOLVED, that this Written Consent may be executed in one or more counterparts, each of which shall be deemed an original and together they shall be deemed one and the same instrument.

 

[Signature pages follow]

 

20

 

 

IN WITNESS WHEREOF, the undersigned have executed this Written Consent as of the date first written above.

 

  Sole Member:
   
  AVALON GLOBOCARE CORP.

 

     
  Name:  
  Title:  

 

 

 

 

 

EX-101.SCH 3 albt-20231117.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 albt-20231117_lab.xml XBRL LABEL FILE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 5 albt-20231117_pre.xml XBRL PRESENTATION FILE XML 6 R1.htm IDEA: XBRL DOCUMENT v3.23.3
Cover
Nov. 17, 2023
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Nov. 17, 2023
Entity File Number 001-38728
Entity Registrant Name AVALON GLOBOCARE CORP.
Entity Central Index Key 0001630212
Entity Tax Identification Number 47-1685128
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 4400 Route 9 South
Entity Address, Address Line Two Suite 3100
Entity Address, City or Town Freehold
Entity Address, State or Province NJ
Entity Address, Postal Zip Code 07728
City Area Code 732
Local Phone Number 780-4400
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, $0.0001 par value per share
Trading Symbol ALBT
Security Exchange Name NASDAQ
Entity Emerging Growth Company true
Elected Not To Use the Extended Transition Period false
XML 7 ea188870-8k_avalonglobo_htm.xml IDEA: XBRL DOCUMENT 0001630212 2023-11-17 2023-11-17 iso4217:USD shares iso4217:USD shares 0001630212 false 8-K 2023-11-17 AVALON GLOBOCARE CORP. DE 001-38728 47-1685128 4400 Route 9 South Suite 3100 Freehold NJ 07728 732 780-4400 false false false false Common Stock, $0.0001 par value per share ALBT NASDAQ true false EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.3 html 1 24 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://avalon-globocare.com/role/Cover Cover Cover 1 false false All Reports Book All Reports albt-20231117.xsd albt-20231117_lab.xml albt-20231117_pre.xml ea188870-8k_avalonglobo.htm http://xbrl.sec.gov/dei/2023 true false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "ea188870-8k_avalonglobo.htm": { "nsprefix": "ALBT", "nsuri": "http://avalon-globocare.com/20231117", "dts": { "schema": { "local": [ "albt-20231117.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "labelLink": { "local": [ "albt-20231117_lab.xml" ] }, "presentationLink": { "local": [ "albt-20231117_pre.xml" ] }, "inline": { "local": [ "ea188870-8k_avalonglobo.htm" ] } }, "keyStandard": 24, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 59, "unitCount": 3, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 24 }, "report": { "R1": { "role": "http://avalon-globocare.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "AsOf2023-11-17", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "p", "body", "html" ], "reportCount": 1, "baseRef": "ea188870-8k_avalonglobo.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-11-17", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "p", "body", "html" ], "reportCount": 1, "baseRef": "ea188870-8k_avalonglobo.htm", "first": true, "unique": true } } }, "tag": { "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r17" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAccountingStandard", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r13" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r10" ] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r13" ] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CountryRegion", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r8" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPrimarySicNumber", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r14" ] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r2" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r2" ] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r5" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r2" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r2" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r2" ] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r11", "r13", "r14" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r2" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r4" ] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r12" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r19" ] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r14" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AnnualInformationForm", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r14" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r15" ] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Extension", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r6" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r1" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r7" ] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r2" ] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodStartDate", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r3" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityReportingObligation", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r9" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r18" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyReport", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r0" ] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r16" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://avalon-globocare.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r13" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r10": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r11": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r12": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r13": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r14": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r15": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r16": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r17": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r18": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r19": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 14 0001213900-23-089631-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001213900-23-089631-xbrl.zip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